Abstract
COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Current Respiratory Medicine Reviews
Title: COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities
Volume: 5 Issue: 2
Author(s): Ioannis Starakis
Affiliation:
Abstract: COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Export Options
About this article
Cite this article as:
Starakis Ioannis, COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities, Current Respiratory Medicine Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339809788189923
DOI https://dx.doi.org/10.2174/157339809788189923 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell Hierarchy, Metabolic Flexibility and Systems Approaches to Cancer Treatment
Current Pharmaceutical Biotechnology Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology COX-2 Inhibitors and Cardiovascular Events: Deja Vu Du Jour
Vascular Disease Prevention (Discontinued) Molecular Mechanisms Underlying Psychological Stress and Cancer
Current Pharmaceutical Design Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications
Current Pharmaceutical Design Beta-2 Agonists in Asthma: Medicine or Murderer?
Current Respiratory Medicine Reviews microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production
Current Pharmaceutical Design Musculoskeletal Adverse Drug Reactions: A Review of Literature and Data from ADR Spontaneous Reporting Databases
Current Drug Safety Central Arterial Aging and Angiotensin II Signaling
Current Hypertension Reviews Quality and Safety in Pediatric Complex Care
Current Pediatric Reviews Biomarkers in Atrial Fibrillation and Heart Failure
Current Medicinal Chemistry Impact of DNA Vector Topology on Non-Viral Gene Therapeutic Safety and Efficacy
Current Gene Therapy Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling
Current Stem Cell Research & Therapy High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Combination of Therapeutic Hypothermia and Other Neuroprotective Strategies after An Ischemic Cerebral Insult
Current Neuropharmacology Role of Nitrosative Stress and Poly(ADP-ribose) Polymerase Activation in Diabetic Vascular Dysfunction
Current Vascular Pharmacology The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Current Drug Therapy